Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease
- PMID: 20394043
- PMCID: PMC6653572
- DOI: 10.1002/clc.20724
Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease
Abstract
Background: HMG-CoA reductase inhibitors (statins) have antiatherogenic effects beyond their cholesterol-lowing effect. Whether atorvastatin has a stronger antioxidant effect than other statins is uncertain.
Hypothesis: To determine the effects of simvastatin and atorvastatin on markers of oxidative stress in patients with coronary heart disease (CHD).
Methods: This study was comprised of 164 patients with CHD and a control population of 122 healthy subjects. The patients with CHD were divided into 2 groups and treated with either simvastatin 20 mg/day or atorvastatin 10 mg/day. The markers of oxidative stress were measured before and after 12 weeks of treatment.
Results: The effects of atorvastatin on reducing oxidative stress were significantly greater compared with those of simvastatin (P < 0.05). The changes in the markers of oxidative stress did not correlate with the changes in the plasma lipid profile (P > 0.05).
Conclusions: This study suggests that atorvastatin reduces oxidative stress more effectively than simvastatin.
Copyright 2010 Wiley Periodicals, Inc.
Similar articles
-
Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial).Am J Cardiol. 1999 Jul 1;84(1):7-13. doi: 10.1016/s0002-9149(99)00183-6. Am J Cardiol. 1999. PMID: 10404843 Clinical Trial.
-
No effect of atorvastatin and simvastatin on oxidative stress in patients at high risk for cardiovascular disease.Neth J Med. 2013 Sep;71(7):359-65. Neth J Med. 2013. PMID: 24038561 Clinical Trial.
-
Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease.Pharmacotherapy. 2001 Apr;21(4):410-5. doi: 10.1592/phco.21.5.410.34491. Pharmacotherapy. 2001. PMID: 11310513 Clinical Trial.
-
Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.Drugs. 2001;61(12):1835-81. doi: 10.2165/00003495-200161120-00012. Drugs. 2001. PMID: 11693468 Review.
-
Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.Am Heart J. 2006 Feb;151(2):273-81. doi: 10.1016/j.ahj.2005.04.003. Am Heart J. 2006. PMID: 16442888 Review.
Cited by
-
Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study.Indian Heart J. 2015 May-Jun;67(3):227-32. doi: 10.1016/j.ihj.2015.03.016. Epub 2015 Apr 27. Indian Heart J. 2015. PMID: 26138179 Free PMC article.
-
Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography.ARYA Atheroscler. 2014 Sep;10(5):252-8. ARYA Atheroscler. 2014. PMID: 25477982 Free PMC article.
-
The Antinociceptive Effects of Combined Treatment With Atorvastatin and Vitamin C in the Chronic Constriction Injury Model of Rats.Basic Clin Neurosci. 2023 Nov-Dec;14(6):727-739. doi: 10.32598/bcn.2022.895.2. Epub 2023 Nov 1. Basic Clin Neurosci. 2023. PMID: 39070196 Free PMC article.
-
PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca2+ regulation.J Cell Mol Med. 2020 Aug;24(16):9189-9203. doi: 10.1111/jcmm.15556. Epub 2020 Jul 6. J Cell Mol Med. 2020. PMID: 32628813 Free PMC article.
-
Oxidative stress and kidney injury in trans-radial catheterization.Biomed Rep. 2018 May;8(5):417-425. doi: 10.3892/br.2018.1071. Epub 2018 Feb 28. Biomed Rep. 2018. PMID: 29732146 Free PMC article.
References
-
- Wenger NK, Shaw LJ, Vaccarino V. Coronary heart disease in women: update 2008. Clin Pharmacol Ther 2008; 83: 37–51. - PubMed
-
- Ishibashi Y, Takahashi N, Tokumaru A, et al. Effects of long‐term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease. J Cardiovasc Pharmacol 2008; 51: 311–316. - PubMed
-
- Buijsse B, Feskens EJ, Moschandreas J, et al. Oxidative stress, and iron and antioxidant status in elderly men: differences between the Mediterranean south (Crete) and northern Europe (Zutphen). Eur J Cardiovasc Prev Rehabil 2007; 14: 495–500. - PubMed
-
- Canales A, Benedí J, Nus M, et al. Effect of walnut‐enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra CHD‐risk factor. J Am Coll Nutr 2007; 26: 225–232. - PubMed
-
- Suys B, de Beeck LO, Rooman R, et al. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatr Res 2007; 62: 456–461. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical